Clinical evaluation of a trabecular microbypass stent with phacoemulsification in patients with open-angle glaucoma and cataract.
OBJECTIVE
To evaluate the safety and efficacy of the iStent trabecular microbypass stent in combination with cataract surgery in patients with open-angle glaucoma (OAG).


METHODS
Retrospective, consecutive case series from October 2012 to December 2015 with no exclusion criteria. The series comprised of 350 eyes with OAG and cataract. Data were collected both preoperatively and postoperatively at day 1 week 1, months 1, 3, 6, 12, 18, and 24. Data included intraocular pressure (IOP), number of glaucoma medications, visual acuity, the incidence of postoperative IOP pressure spikes of greater than ≥15 mmHg at any time point, and need for additional surgery.


RESULTS
The mean preoperative IOP was 19.13±6.34 mmHg. At 2 years postoperation, mean IOP was 15.17±3.53 mmHg (P<0.0001). The mean number of glaucoma medications was 1.19±1.00 preoperatively and 0.61±0.96 (P<0.0001) at 2 years postoperation. At 1 day postoperatively, 31 eyes (12.4%) experienced an IOP increase of 15 mmHg above their baseline IOP that responded to topical therapy. Two patients required additional tube shunt surgery.


CONCLUSIONS
The insertion of the iStent trabecular microbypass stent in combination with cataract surgery effectively lowers IOP in OAG patients. The magnitude of IOP reduction was more significant in patients with higher preoperative pressure. Medication use was also significantly reduced postoperatively. The safety profile appears favorable with a low rate of IOP spikes and only two eyes (<1%) requiring additional surgery.
Sanford School of Medicine, University of South Dakota, Sanford School of Medicine, Sioux Falls, SD, USA.
Tanner J
TJ
Ferguson
Vance Thompson Vision, Sioux Falls, SD, USA.
John P
JP
Berdahl
Vance Thompson Vision, Sioux Falls, SD, USA.
Justin A
JA
Schweitzer
Sanford School of Medicine, University of South Dakota, Sanford School of Medicine, Sioux Falls, SD, USA.
Ramu G
RG
Sudhagoni
glaucoma; glaucoma surgery; iStent; microinvasive glaucoma surgery; open-angle glaucoma; trabecular microbypass stent
J Cataract Refract Surg. 2010 Mar;36(3):407-12
20202537
Cornea. 2004 Jul;23(5):490-6
15220734
Br J Ophthalmol. 2006 Mar;90(3):262-7
16488940
Arch Ophthalmol. 2002 Oct;120(10):1268-79
12365904
Eur J Ophthalmol. 2009 May-Jun;19(3):393-9
19396784
Ophthalmology. 2011 Mar;118(3):459-67
20828829
J Cataract Refract Surg. 2008 May;34(5):735-42
18471626
Br J Ophthalmol. 2012 May;96(5):645-9
22275344
J Glaucoma. 2012 Mar;21(3):189-92
21336146
Curr Opin Ophthalmol. 2012 Mar;23(2):96-104
22249233
Can J Ophthalmol. 2014 Dec;49(6):528-33
25433743
Am J Ophthalmol. 2007 Oct;144(4):533-40
17686450
J Cataract Refract Surg. 2012 Aug;38(8):1339-45
22814041
Ophthalmic Surg Lasers. 1999 Jan;30(1):37-40
9923491
J Cataract Refract Surg. 2001 Nov;27(11):1779-86
11709251
Am J Ophthalmol. 2009 Nov;148(5):670-84
19674729
Am J Ophthalmol. 2004 Dec;138(6):988-94
15629290